Demonstration of mRNA for five species of cytochrome P450 in human bone marrow, bone marrow-derived macrophages and human haemopoietic cell lines

British Journal of Haematology

Volumn 108, Issue 1, 2000, Pages 151-156

  Hodges, Vivien M ^a   Molloy, Gael Y ^a   Wickramasinghe, S N ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Bone marrow; Cytochrome P450s; Haemopoietic cell lines; Macrophages; MRNA expression

Indexed keywords

CYTOCHROME P450 ISOENZYME; MESSENGER RNA;

ARTICLE; BONE MARROW; CELL LINE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; XENOBIOTIC METABOLISM;

BONE MARROW; CELL LINE; CYTOCHROME P-450 ENZYME SYSTEM; HEMATOPOIETIC STEM CELLS; HUMANS; MACROPHAGES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033969893     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01816.x     Document Type: Article

References (46)

1. Abraham, N.G., Feldman, E., Falck, J.R., Lutton, J.D. & Schwartzman, M.L. (1991) Modulation of erythropoiesis by novel human bone marrow cytochrome P450-dependent metabolites of arachidonic acid. Blood. 78, 14-1466.
2. Albertini, R.S. & Penders, T.M. (1978) Agranulocytosis associated with tricyclics. Journal of Clinical Psychiatry. 39, 483-485.
3. Andersen, M.R., Farin, P.M. & Omiecinski, C.J. (1998) Quantification of multiple human cytochrome P450 mRNA molecules using competitive reverse transcriptase-PCR. DNA and Cell Biology, 17, 231-238.
4. Baron, J.M., Zwaldo-Klanvasser, G., Jugert, F., Hamann, W., Rübben, A., Mukhtar, H. & Merk, H.F. (1998) Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochemical Pharmacology, 56, 1105-1110.
5. Bosch, X. & Vera, M. (1998) Aplastic anaemia during treatment with fluoxetine. Lancet. 35, 1031.
6. Chang, T.K., Yu. L., Maurel, P. & Waxman, D.J. (1997) Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures; response to cytochrome P450 inducers and autoinduction by oxazaphosphorines. Cancer Research, 57, 1946-1954.
7. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Analytical Biochemistry, 16, 6-9.
8. Daly, A.K. (1995) Molecular basis of polymorphic drug metabolism. Journal of Molecular Medicine, 73, 539-553.
9. Daly, A.K., Cholerton, S., Armstrong. M. & Idle. J.R. (1994) Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environmental Health Perspectives, 10, 55-61.
10. Draper, B.M. & Manoharan, A. (1987) Neutropenia with cross-intolerance between two tricyclic antidepressant agents. Medical Journal of Australia, 14, 452-453.
11. Gonzales, F.J. & Meyer, U.A. (1991) Molecular genetics of the debrisoquine-sparteine polymorphism. Clinical Pharmacology and Therapeutics, 50, 233-238.
12. Guengerich, P.P., Kirn, D.-H. & Iwasaki, M. (1991) Role of human cytochrome P450-IIE1 in the oxidation of many low molecular weight cancer suspects. Chemical Research in Toxicology, 4, 168-179.
13. Gut. I., Nedelcheva, V, Soucek, P., Stopka, P. & Tichavska, B. (1996) Cytochrome P450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity. Environmental Health Perspectives, 10, 1211-1218.
14. Hakkola, J., Fasanen, M., Hukkanen, J., Pelkonen, O., Maenpaa, J., Edwards, R.J., Boobis, A.R. & Raunio, H. (1996) Expression of xenobiotic metabolizing cytochrome P450 forms in human full-term placenta. Biochemical Pharmacology, 51, 403-411.
15. Hayashi, S., Watanabe. J. & Kawajiri, K. (1991) Genetic polymorphism in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. Journal of Biochemistry, Tokyo, 11, 559-565.
16. Hukkanen, J., Hakkola, J., Anttila, S., Piipari, R., Karjalainen, A., Pelkonen, 0. & Raunio, H. (1997) Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes. Molecular Carcinogenesis, 20, 224-230.
17. Hutson, J.L. & Wickramasinghe, S.N. (1998) Human monocyte-derived macrophages express CYP2E1. Journal of Pathology. 18, 22 A.
18. Hutson, J.L. & Wickramasinghe. S.N. (1999) Expression of CYP2E1 by human monocyte-derived macrophages. Journal of Pathology, 18,197-200.
19. Idanpaan-Heikkila, J., Alhava, E., OIkinuora. M. & Palva, I.P. (1977) Agranulocytosis during treatment with clozapine. European Journal of Clinical Pharmacology, 11, 193-198.
20. Kizaki, M., Ueno, H., Yamazoe, Y., Shimada, M., Takayama, N., Muto, A., Matsushita, H., Nakajima, H., Morikawa, M., Koefiler, H.P. & Ikeda, Y. (1996) Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein. Blood, 87, 72-733.
21. Koop, D.R. (1992) Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB Journal. 6, 724-730.
22. Koskela, S., Hakkola, J., Hukkanen, ]., Pelkonen, O., Sorri, M., Saranen, A., Anttila, S., Fernandez-Salguero, P., Gonzalez, F. & Raunio, H. (1999) Expression of CYP2A genes in human liver and extrahepatic tissues. Biochemical Pliarmacology, 57, 1407-1413.
23. Kroemer, U.K. & Eichelbaum, M. (1995) Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism. Life Sciences, 56, 2285-2298.
24. Laidlaw, S.T., Snowden, J.A. & Brown, M.J. (1993) Aplastic anaemia and rcmoxipride (letter). Lancet, 34, 1245.
25. Levere, R.D. & Ibrahim, N.G. (1982) The bone marrow as a metabolic organ. American Journal of Medicine. 73, 615-616.
26. McCord, A., Boyle, S.P., Knowler, J.T., Burnett, A.K. & Craft, J.A. (1996) Metabolism of benz (alpha) anthracene by human bone marrow in vitro. Chemico-Biological Interactions, 99, 29-40.
27. Mahgoub, A., Idle, J.R., Dring, L.G., Lancaster, R. & Smith, R.L. (1977) Polymorphic hydroxylation of debrisoquine in man. Lancet, ii, 584-586.
28. Marsh, J.C.W., Abboudi, Z.H., Gibson, P.M., Scopes, J., Daly, S., O'Shaunnessy, D.F., Baughan, A.S.J. & Gordon-Smith, B.C. (1994) Aplastic anaemia following exposure to 3,4-methylenedioxy-methamphetamine ('Ecstasy'). Britisli Journal of Haematology, 88, 281-285.
29. Marsh, J.C.W., Chowdry, J., Parry-Jones, N., Ellis, S.W., Muir, K.R., Gordon-Smith, E.C. &Tucker, G.T. (1999) Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia. British Journal of Haematology. 10, 266-270.
30. Meyer, U.A. & Zanger, U.M. (1997) Molecular mechanisms of genetic polymorphisms of drug metabolism. Annual Reviews of Pharmacology and Toxicology, 37, 269-296.
31. Nakagawara, A., Nathan, C.F. & Cohn. Z.A. (1981) Hydrogen peroxide metabolism in human monocytes during differentiation in vitro. Journal of Clinical Investigation, 68, 1243-1252.
32. Gates, N.S., Shah, R.R., Drury, P.L., Idle, J.E. & Smith, R.L. (1982) Captopril-induced agranulocytosis associated with an impairment of debrisoquine hydroxylation. British Journal of Clinical Pharmacology, 14, 601P.
33. Peterson, T.C. (1987) Drug-metabolizing enzymes in rat, mouse, pig and human macrophages and the effect of phagocytic activation. Biochemical Pharmacology. 36, 3911-3916.
34. Philpott, N.J., Marsh, J.C.W. & Gordon-Smith, E.C. (1993) Aplastic anaemia and remoxipride. Lancet, 34, 1244-1245.
35. Raizman, M.B., Fay, A.M. & Weiss, J.S. (1994) Dapsone-induced neutropenia in patients treated for ocular cicatricial pemphigoid. Ophthalmology. 10, 1805-1807.
36. Raunio, H., Hakkola, J., Hukkanen, J., Pelkonen, O., Edwards, R., Boobis, A. & Anttila, S. (1998) Expression of xenobiotic-metabolizing cytochrome P450s in human pulmonary tissues. Archives of Toxicology Supplement, 20, 465-469.
37. Ritchie, J.C., Crothers. M.J., Shah, R.R., Idle, J.R. & Smith, R.L. (1986) The metabolism of debrisoquine in man: (1) regioselectivity of hydroxylation and aberrant oxidative metabolism in two sibling patients with carbimazole-induced agranulocytosis. Xenobioticn, 16, 50-509.
38. Schnier, G.G., Laethem, C.L. & Koop, D.R. (1989) Identification and induction of cytochromes P450, P450IIE1 and P450IA1 in rabbit bone marrow. Journal of Pharmacology and Experimental Therapeutics, 25, 790-796.
39. Starkel, P., Sempoux, C., Van Den Berge, V, Stevens, M., De Saeger, C., Desager, J.P. & Horsmans, Y. (1999) CYP 3A proteins are expressed in human neutrophils and lymphocytes but are not induced by rifampicin. Life Sciences, 64, 643-653.
40. Tucker. G.T., Silas, J.H., lyun, A.O., Lennard. M.S. & Smith, A.J. (1977) Polymorphic hydroxylation of debrisoquine. Lancet, 2, 71.
41. Vanden Heuvel, J.P., Clark, G.C., Thompson, C.L, McCoy, Z., Miller, C.R., Lucien G.W. & Bell, D.A. (1993) CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Carrinogenesis, 14, 2003-2006.
42. Wickramasinghe, S.N. (1987) Evidence of drug metabolism by macrophages: possible role of macrophages in the pathogenesis of drug-induced tissue damage and in the activation of environmental procarcinogens. Clinical and Laboratory Haematology, 9, 271-280.
43. Wickramasinghe, S.N. (1998) Ethanol metabolism by macrophages: possible role in organ damage. Addiction Biology. 3, 405-412.
44. Wickramasinghe, S.N. & Hasan, R. (1993) Possible role of macrophages in the pathogenesis of ethanol-induced bone marrow damage. British Journal of Haematology. 83, 574-579.
45. Wilkinson, G.R. (1996) Cytochrome P4503A (CYP3A) metabolism: prediction of i;i vivo activity in humans. Journal of Pharmacokinetics and Biophannaceutics, 24, 475-490.
46. Yokoi, T. & Kamataki, T. (1998) Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese. Pharmaceutical Research. 15, 517-524.